Levitee Labs Inc.

Equities

LVT

CA5274241051

Food Processing

Market Closed - Canadian Securities Exchange 11:03:02 2023-02-01 EST 5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for Levitee Labs Inc. -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Levitee Labs Inc. Announces Executive Changes CI
Levitee Labs Inc. Announces CEO Changes CI
Levitee Labs Inc. Announces Philip Van Den Berg to Join as Interim CEO CI
Levitee Labs Inc. Announces Philip Van Den Berg to Join the Board of Directors CI
Levitee Labs Inc. announced that it expects to receive CAD 3 million in funding CI
Levitee Labs Inc Signs Retail Distribution Agreement with Body Energy Club for MONKE Nutraceuticals CI
Levitee Labs Inc. Enters into A Strategic Partnership Via A Services Agreement with Canntab Therapeutics Limited CI
Levitee Labs Inc. Appoints Maigul Wickham as its Chief Financial Officer Replacing Mason Darabi CI
Levitee Labs Announces Medical Advisory Board CI
Levitee Labs Inc. Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care Throughout Alberta, Canada CI
Levitee Labs Inc. Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region CI
Levitee Labs Inc. Announces Unaudited Consolidated Revenue Results for the Month of September and October 2021 CI
Levitee Labs to Seek Acquisitions CI
Levitee?Labs Enters into Credit Facility For Up To $12 Million CI
Levitee Labs Inc. announced that it expects to receive $12 million in funding CI
Levitee Labs Announces Agreement with Adracare, a WELL Health Company, to Support Individuals with Addiction and Mental Health Conditions CI
Levitee Labs Appoints Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada CI
Levitee Labs : Signs Letter of Intent to Acquire Calgary-Based Compounding Pharmacy MT
Levitee Labs Inc. entered into a letter of intent to acquire 51% of the issued and outstanding shares in Compounding Pharmacy in Calgary, Alberta, Canada for CAD 0.306 million. CI
Levitee Labs Inc. Announces Unaudited Consolidated Revenue Results for the Month of August 2021 CI
Levitee Labs : Canadian Wellness Company Levitee Labs Lists on Frankfurt Bourse MT
Levitee Labs : Up 2.5% as Reports DTC Eligibility Approval MT
Levitee Labs : Reports DTC Eligibility Approval MT
Levitee Labs Inc. Announces Azim Qazi as Head of Ecommerce and Consumer Packaged Goods CI
Levitee Labs Appoints Fady Hannah-Shmouni as Chief Medical and Scientific Officer and President of Levitee Clinics and Pharmacies CI
Chart Levitee Labs Inc.
More charts
Levitee Labs Inc. is a Canada-based integrative wellness company. The Company focuses on the centralization of integrative wellness assets. It is involved in transforming the traditional landscape of mental health, addiction, and pain management treatments through evidence-based complementary medicines and psychedelic therapies through its portfolio of wellness assets. The Company’s portfolio of assets includes Levitee Clinics, Levitee Pharmacies, Levitee Nutraceuticals and Sporeo. Levitee Clinics is a group of five operating addiction and pain treatment clinics in Alberta. Levitee Pharmacies includes three pharmacies operating in Alberta specialized in filling prescriptions for patients with substance use disorders, mental health conditions, and chronic pain. Levitee Nutraceuticals includes MONKE Nutra, Ojio, Earth Shift and Earth Circle Organics. Sporeo products are available through retail, wholesale, and ecommerce channels and defragments the mushroom cultivation ecosystem.
More about the company
  1. Stock Market
  2. Equities
  3. LVT Stock
  4. News Levitee Labs Inc.
  5. Levitee Labs : Canadian Wellness Company Levitee Labs Lists on Frankfurt Bourse